Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response

16 Dec 2017

Abstract excerpt

// Alexander P. Glaser 1, 2 , Damiano Fantini 1, 2 , Yiduo Wang 1, 2 , Yanni Yu 1, 2 , Kalen J. Rimar 1, 2 , Joseph R. Podojil 3 , Stephen D. Miller 3 and Joshua J. Meeks 1, 2 1 Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA 2 Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA 3 Interdepartmental Immunobiology Center, Department of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29435122
DOI: 10.18632/oncotarget.23344

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responsePMID 29435122Read ↗

APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune responseSemantic proximity Read ↗

APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databasesSemantic proximity Read ↗

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.Semantic proximity Read ↗

Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.Semantic proximity Read ↗

The cytidine deaminase APOBEC3G drives cancer mutagenesis and clonal evolution in bladder cancerSemantic proximity Read ↗

Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection.Semantic proximity Read ↗

Mutational Context and Diverse Clonal Development in Early and Late Bladder CancerSemantic proximity Read ↗

Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progressionSemantic proximity Read ↗

Racial differences in genomic features and new trans-ancestry prognosis subtypes in bladder cancerSemantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

Predicting immunotherapy response in advanced bladder cancer: a meta-analysis of six independent cohortsSemantic proximity Read ↗

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.